Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
2.2 Definitions
13
2.2.1 Wound Care Management 13
2.2.1.1 Traditional Wound Management
13
2.2.1.2 Advanced Wound Management 13
2.2.1.3 Wound Closure Devices
13
2.2.1.4 Ostomy 14
2.2.1.5 Compression Therapy 14
3 Healthcare
Sector Review 15
4 Wound Care Management in Egypt 16
4.1 Wound Care
Management Overall Revenues (2000-2012) 16
4.2 Wound Care Management
Overall Volume (2000-2012) 22
4.3 Wound Care Management Overall Company
Shares (2005-2006) 25
5 Wound Closure Devices in Egypt 26
5.1 Wound
Closure Devices Overall Revenues (2000-2012) 26
5.1.1 Skin Closure Devices
Overall Revenues (2000-2012) 30
5.1.2 Hemostats Overall Revenues
(2000-2012) 32
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 34
5.2 Wound Closure Devices Overall Volume (2000-2012) 36
5.2.1 Skin Closure
Devices Overall Volume (2000-2012) 38
5.2.2 Hemostats Overall Volume
(2000-2012) 40
5.2.3 Tissue Sealants Overall Volume (2000-2012) 42
5.3
Wound Closure Devices Average Price (2000-2012) 44
5.3.1 Hemostats Average
Price (2000-2012) 44
5.3.2 Tissue Sealants Average Price (2000-2012)
46
5.3.3 Skin Closure Devices Average Price (2000-2012) 48
5.4 Wound
Closure Devices Distribution Share (2005-2006) 50
5.5 Wound Closure
Devices Company Share (2005-2006) 51
6 Ostomy in Egypt 52
6.1 Ostomy
Overall Revenue (2000-2012) 52
6.2 Ostomy Overall Volume (2000-2012)
54
6.3 Ostomy Average Price (2000-2012) 56
6.4 Ostomy Distribution
Share (2005-2006) 58
6.5 Ostomy Company Share (2005-2006) 59
7
Advanced Wound Management in Egypt 60
7.1 Advanced Wound Management
Overall Revenue (2000-2012) 60
7.2 Advanced Wound Management Overall
Volume (2000-2012) 62
7.3 Advanced Wound Management Average Price
(2000-2012) 64
7.4 Advanced Wound Management Distribution Share
(2005-2006) 66
7.5 Advanced Wound Management Company Share (2005-2006)
67
8 Traditional Wound Management in Egypt 68
8.1 Traditional Wound
Management Overall Revenue (2000-2012) 68
8.2 Traditional Wound Management
Overall Volume (2000-2012) 70
8.3 Traditional Wound Management Average
Price (2000-2012) 72
8.4 Traditional Wound Management Distribution Share
(2005-2006) 74
8.5 Traditional Wound Management Company Share (2005-2006)
75
9 Compression Therapy in Egypt 76
9.1 Compression Therapy Overall
Revenue (2000-2012) 76
9.2 Compression Therapy Overall Volume (2000-2012)
78
9.3 Compression Therapy Average Price (2000-2012) 80
9.4
Compression Therapy Distribution Share (2005-2006) 82
9.5 Compression
Therapy Company Share (2005-2006) 83
10 Baxter International Company
Profile 84
10.1 Company Overview 84
10.2 Business Overview 84
10.2.1 BioScience 84
10.2.2 Medication Delivery 84
10.2.3 Renal 85
10.2.4 Products 85
10.2.5 History 86
10.3 Value Chain Analysis 89
10.3.1 Manufacturing 89
10.3.2 Product Development 89
10.3.3 Sales and
Marketing 90
10.4 SWOT Analysis 91
10.4.1 Baxter International Inc.
Strengths 91
10.4.2 Baxter International Inc. Weaknesses 92
10.4.3
Baxter International Inc. Opportunities 92
10.4.4 Baxter International
Inc. Threats 93
10.5 Financial and Operational Review 94
10.6
Locations And Subsidiaries 96
10.7 Other Locations & Subsidiaries 96
10.8 Baxter International Inc. Pipeline Products 97
10.8.1 Next-Generation
Home Hemodialysis Machine 97
10.8.1.1 Product Overview 97
10.8.1.2
Product Description 97
10.8.1.3 Product Status 98
10.8.1.4 Product
Milestone 98
11 Covidien Ltd./Tyco Healthcare Company Profile 99
11.1
Company Overview 99
11.2 Business Overview 99
11.2.1 Imaging Solutions
99
11.2.2 Medical Devices 99
11.2.3 Medical Supplies 100
11.2.4
Pharmaceutical Products 101
11.2.5 Retail Products 101
11.2.6 Products
102
11.2.7 History 103
11.3 Value Chain Analysis 104
11.3.1
Manufacturing 104
11.3.2 Product Development 104
11.3.3 Sales and
Marketing 106
11.4 SWOT Analysis 106
11.4.1 Covidien Ltd./Tyco
Healthcare Strengths 107
11.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
108
11.4.3 Covidien Ltd./Tyco Healthcare Opportunities 109
11.4.4
Covidien Ltd./Tyco Healthcare Threats 109
11.5 Financial and Operational
Review 110
11.5.1 Financial Statements 110
11.5.2 Financial Ratios
111
11.6 Locations And Subsidiaries 112
11.7 Other Locations &
Subsidiaries 112
11.8 Covidien Ltd./Tyco Healthcare Pipeline Products
113
11.8.1 PleuraSeal Lung Sealant System 113
11.8.1.1 Product
Overview 113
11.8.1.2 Product Description 113
11.8.1.3 Product Status
113
11.8.1.4 Product Milestone 113
11.8.2 Sandman Intro CPAP Device
114
11.8.2.1 Product Overview 114
11.8.2.2 Product Description 114
11.8.2.3 Product Status 114
11.8.2.4 Product Milestone 114
12 3M
Company Profile 116
12.1 Company Overview 116
12.2 Business Overview
116
12.2.1 Consumer and Office 116
12.2.2 Display and Graphics 116
12.2.3 Electro and Communications 117
12.2.4 Health Care 117
12.2.5
Industrial and Transportation 118
12.2.6 Safety, Security and Protection
Services 119
12.2.7 Products 119
12.3 Value Chain Analysis 121
12.3.1 Manufacturing 122
12.3.2 Product Development 122
12.3.3 Sales
and Marketing 122
12.4 SWOT Analysis 123
12.4.1 3M Company Strengths
123
12.4.2 3M Company Weaknesses 124
12.4.3 3M Company Opportunities
124
12.4.4 3M Company Threats 125
12.5 Financial and Operational
Review 126
12.6 Locations And Subsidiaries 127
12.6.1 Other Locations
& Subsidiaries 128
13 Ethicon, Inc. Company Profile 129
13.1 Company
Overview 129
13.2 Business Overview 129
13.2.1 Products 130
13.3
Locations And Subsidiaries 130
13.3.1 Other Locations & Subsidiaries
131
14 ConvaTec Company Profile 132
14.1 Company Overview 132
14.2
Business Overview 132
14.2.1 Major Products and Services 132
14.2.2
History 133
14.3 Locations And Subsidiaries 134
14.3.1 Other Locations
& Subsidiaries 134
15 Regulation System 135
15.1 Approval Process
135
15.2 Registration Procedures 136
15.3 Registration of Class I,
Class IIa and Class IIb devices at DPPC 136
15.4 Declaration of Conformity
(Self certification) 137
15.5 Free Sale Certificate 137
15.6 CE
Certificate 138
16 Pricing and Reimbursement 139
17 Distribution
Structure 140
18 Appendix 141
18.1 Global Markets Direct Research
Methodology 141
18.2 Coverage 142
18.3 Secondary Research 142
18.4
Primary Research 143
18.5 Models 143
18.6 Forecasts 144
18.7
Expert Panels 144
18.8 Currency Conversion 145
18.9 Contact Us 146
18.10 Disclaimer 146
1.1 List of Tables
Table 1: Wound Care
Management, Egypt, Overall Revenues ($ mn), 2000-2012 16
Table 2: Wound
Care Management, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 17
Table 3: Wound Care Management, Egypt, Overall Revenues ($ mn), Forecast,
2007-2012 18
Table 4: Wound Care Management, Egypt, Category Revenues ($
mn), 2000-2012 19
Table 5: Wound Care Management, Egypt, Category Revenues
($ mn), Historic, 2000-2007 20
Table 6: Wound Care Management, Egypt,
Category Revenues ($ mn), Forecast, 2007-2012 21
Table 7: Wound Care
Management, Egypt, Category Volume (Units), 2000-2012 22
Table 8: Wound
Care Management, Egypt, Category Volume (Units), Historic, 2000-2007 23
Table 9: Wound Care Management, Egypt, Category Volume (Units), Forecast,
2007-2012 24
Table 10: Wound Care Management, Egypt, Overall Company Share
by Revenue ($ mn), 2005-2006 25
Table 11: Wound Closure Devices, Egypt,
Overall Revenues ($ mn), Historic, 2000-2007 26
Table 12: Wound Closure
Devices, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 27
Table 13:
Wound Closure Devices, Egypt, Revenue by Segment ($ mn), Historic, 2000-2007
28
Table 14: Wound Closure Devices, Egypt, Revenue by Segment ($ mn),
Forecast, 2007-2012 29
Table 15: Skin Closure Devices, Egypt, Overall
Revenues ($ mn), Historic, 2000-2007 30
Table 16: Skin Closure Devices,
Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 31
Table 17:
Hemostats, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 32
Table
18: Hemostats, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 33
Table 19: Tissue Sealants, Egypt, Overall Revenues ($ mn), Historic, 2000-2007
34
Table 20: Tissue Sealants, Egypt, Overall Revenues ($ mn), Forecast,
2007-2012 35
Table 21: Wound Closure Devices, Egypt, Overall Volume
(Units), Historic, 2000-2007 36
Table 22: Wound Closure Devices, Egypt,
Overall Volume (Units), Forecast, 2007-2012 37
Table 23: Skin Closure
Devices, Egypt, Overall Volume (Units), Historic, 2000-2007 38
Table 24:
Skin Closure Devices, Egypt, Overall Volume (Units), Forecast, 2007-2012
39
Table 25: Hemostats, Egypt, Overall Volume (Units), Historic, 2000-2007
40
Table 26: Hemostats, Egypt, Overall Volume (Units), Forecast, 2007-2012
41
Table 27: Tissue Sealants, Egypt, Overall Volume (Units), Historic,
2000-2007 42
Table 28: Tissue Sealants, Egypt, Overall Volume (Units),
Forecast, 2007-2012 43
Table 29: Hemostats, Egypt, Average Price ($),
Historic, 2000-2007 44
Table 30: Hemostats, Egypt, Average Price ($),
Forecast, 2007-2012 45
Table 31: Tissue Sealants, Egypt, Average Price
($), Historic, 2000-2007 46
Table 32: Tissue Sealants, Egypt, Average
Price ($), Forecast, 2007-2012 47
Table 33: Skin Closure Devices, Egypt,
Average Price ($), Historic, 2000-2007 48
Table 34: Skin Closure Devices,
Egypt, Average Price ($), Forecast, 2007-2012 49
Table 35: Wound Closure
Devices, Egypt, Distribution Share by Revenue ($ mn), 2005-2006 50
Table
36: Wound Closure Devices, Egypt, Company Share by Revenue ($ mn), 2005-2006
51
Table 37: Ostomy, Egypt, Overall Revenues ($ mn), Historic, 2000-2007
52
Table 38: Ostomy, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012
53
Table 39: Ostomy, Egypt, Overall Volume (Units), Historic, 2000-2007
54
Table 40: Ostomy, Egypt, Overall Volume (Units), Forecast, 2007-2012
55
Table 41: Ostomy, Egypt, Average Price ($), Historic, 2000-2007 56
Table 42: Ostomy, Egypt, Average Price ($), Forecast, 2007-2012 57
Table
43: Ostomy, Egypt, Distribution Share by Revenue ($ mn), 2005-2006 58
Table 44: Ostomy, Egypt, Company Share by Revenue ($ mn), 2005-2006 59
Table 45: Advanced Wound Management, Egypt, Overall Revenues ($ mn), Historic,
2000-2007 60
Table 46: Advanced Wound Management, Egypt, Overall Revenues
($ mn), Forecast, 2007-2012 61
Table 47: Advanced Wound Management, Egypt,
Overall Volume (Units), Historic, 2000-2007 62
Table 48: Advanced Wound
Management, Egypt, Overall Volume (Units), Forecast, 2007-2012 63
Table
49: Advanced Wound Management, Egypt, Average Price ($), Historic, 2000-2007
64
Table 50: Advanced Wound Management, Egypt, Average Price ($),
Forecast, 2007-2012 65
Table 51: Advanced Wound Management, Egypt,
Distribution Share by Revenue ($ mn), 2005-2006 66
Table 52: Advanced
Wound Management, Egypt, Company Share by Revenue ($ mn), 2005-2006 67
Table 53: Traditional Wound Management, Egypt, Overall Revenues ($ mn),
Historic, 2000-2007 68
Table 54: Traditional Wound Management, Egypt,
Overall Revenues ($ mn), Forecast, 2007-2012 69
Table 55: Traditional
Wound Management, Egypt, Overall Volume (Units), Historic, 2000-2007 70
Table 56: Traditional Wound Management, Egypt, Overall Volume (Units),
Forecast, 2007-2012 71
Table 57: Traditional Wound Management, Egypt,
Average Price ($), Historic, 2000-2007 72
Table 58: Traditional Wound
Management, Egypt, Average Price ($), Forecast, 2007-2012 73
Table 59:
Traditional Wound Management, Egypt, Distribution Share by Revenue ($ mn),
2005-2006 74
Table 60: Traditional Wound Management, Egypt, Company Share
by Revenue ($ mn), 2005-2006 75
Table 61: Compression Therapy, Egypt,
Overall Revenues ($ mn), Historic, 2000-2007 76
Table 62: Compression
Therapy, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 77
Table 63:
Compression Therapy, Egypt, Overall Volume (Units), Historic, 2000-2007 78
Table 64: Compression Therapy, Egypt, Overall Volume (Units), Forecast,
2007-2012 79
Table 65: Compression Therapy, Egypt, Average Price ($),
Historic, 2000-2007 80
Table 66: Compression Therapy, Egypt, Average Price
($), Forecast, 2007-2012 81
Table 67: Compression Therapy, Egypt,
Distribution Share by Revenue ($ mn), 2005-2006 82
Table 68: Compression
Therapy, Egypt, Company Share by Revenue ($ mn), 2005-2006 83
Table 69:
Baxter International Inc., SWOT Analysis, 2006 91
Table 70: Baxter
International Inc., Financial Statements, USD Million, 2002-2006 94
Table
71: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
95
Table 72: Baxter International Inc., Other Locations 96
Table
73: Baxter International Inc., Subsidiaries 97
Table 74:
Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007 107
Table 75:
Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007
110
Table 76: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD
Million, 2003-2007 111
Table 77: Covidien Ltd./Tyco Healthcare, Other
Locations 112
Table 78: Covidien Ltd./Tyco Healthcare, Subsidiaries
112
Table 79: 3M Company, SWOT Analysis, 2006 123
Table 80:
3M Company, Financial Statements, USD Million, 2002-2006 126
Table 81:
3M Company, Financial and Operational Overview, USD Million, 2002-2006
127
Table 82: 3M Company, Subsidiaries 128
Table 83:
Ethicon, Inc., Other Locations 131
Table 84: Ethicon, Inc.,
Subsidiaries 131
Table 85: ConvaTec, Other Locations 134
Table
86: Currency Conversion from USD to Local Currency at 2007 Constant Rate
145
1.2 List of Figures
Figure 1: Wound Care Management, Egypt,
Overall Revenues ($ mn), 2000-2012 16
Figure 2: Wound Care Management,
Egypt, Overall Revenues ($ mn), Historic, 2000-2007 17
Figure 3: Wound
Care Management, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 18
Figure 4: Wound Care Management, Egypt, Category Revenues ($ mn), 2000-2012
19
Figure 5: Wound Care Management, Egypt, Category Revenues ($ mn),
Historic, 2000-2007 20
Figure 6: Wound Care Management, Egypt, Category
Revenues ($ mn), Forecast, 2007-2012 21
Figure 7: Wound Care Management,
Egypt, Category Volume (Units), 2000-2012 22
Figure 8: Wound Care
Management, Egypt, Category Volume (Units), Historic, 2000-2007 23
Figure
9: Wound Care Management, Egypt, Category Volume (Units), Forecast, 2007-2012
24
Figure 10: Wound Care Management, Egypt, Overall Company Share (%),
2006 25
Figure 11: Wound Closure Devices, Egypt, Overall Revenues ($ mn),
Historic, 2000-2007 26
Figure 12: Wound Closure Devices, Egypt, Overall
Revenues ($ mn), Forecast, 2007-2012 27
Figure 13: Wound Closure Devices,
Egypt, Revenue by Segment ($ mn), Historic, 2000-2007 28
Figure 14: Wound
Closure Devices, Egypt, Revenue by Segment ($ mn), Forecast, 2007-2012 29
Figure 15: Skin Closure Devices, Egypt, Overall Revenues ($ mn), Historic,
2000-2007 30
Figure 16: Skin Closure Devices, Egypt, Overall Revenues ($
mn), Forecast, 2007-2012 31
Figure 17: Hemostats, Egypt, Overall Revenues
($ mn), Historic, 2000-2007 32
Figure 18: Hemostats, Egypt, Overall
Revenues ($ mn), Forecast, 2007-2012 33
Figure 19: Tissue Sealants, Egypt,
Overall Revenues ($ mn), Historic, 2000-2007 34
Figure 20: Tissue
Sealants, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 35
Figure
21: Wound Closure Devices, Egypt, Overall Volume (Units), Historic, 2000-2007
36
Figure 22: Wound Closure Devices, Egypt, Overall Volume (Units),
Forecast, 2007-2012 37
Figure 23: Skin Closure Devices, Egypt, Overall
Volume (Units), Historic, 2000-2007 38
Figure 24: Skin Closure Devices,
Egypt, Overall Volume (Units), Forecast, 2007-2012 39
Figure 25:
Hemostats, Egypt, Overall Volume (Units), Historic, 2000-2007 40
Figure
26: Hemostats, Egypt, Overall Volume (Units), Forecast, 2007-2012 41
Figure 27: Tissue Sealants, Egypt, Overall Volume (Units), Historic, 2000-2007
42
Figure 28: Tissue Sealants, Egypt, Overall Volume (Units), Forecast,
2007-2012 43
Figure 29: Hemostats, Egypt, Average Price ($), Historic,
2000-2007 44
Figure 30: Hemostats, Egypt, Average Price ($), Forecast,
2007-2012 45
Figure 31: Tissue Sealants, Egypt, Average Price ($),
Historic, 2000-2007 46
Figure 32: Tissue Sealants, Egypt, Average Price
($), Forecast, 2007-2012 47
Figure 33: Skin Closure Devices, Egypt,
Average Price ($), Historic, 2000-2007 48
Figure 34: Skin Closure Devices,
Egypt, Average Price ($), Forecast, 2007-2012 49
Figure 35: Wound Closure
Devices, Egypt, Distribution Share (%), 2006 50
Figure 36: Wound Closure
Devices, Egypt, Company Share (%), 2006 51
Figure 37: Ostomy, Egypt,
Overall Revenues ($ mn), Historic, 2000-2007 52
Figure 38: Ostomy, Egypt,
Overall Revenues ($ mn), Forecast, 2007-2012 53
Figure 39: Ostomy, Egypt,
Overall Volume (Units), Historic, 2000-2007 54
Figure 40: Ostomy, Egypt,
Overall Volume (Units), Forecast, 2007-2012 55
Figure 41: Ostomy, Egypt,
Average Price ($), Historic, 2000-2007 56
Figure 42: Ostomy, Egypt,
Average Price ($), Forecast, 2007-2012 57
Figure 43: Ostomy, Egypt,
Company Share (%), 2006 59
Figure 44: Advanced Wound Management, Egypt,
Overall Revenues ($ mn), Historic, 2000-2007 60
Figure 45: Advanced Wound
Management, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 61
Figure
46: Advanced Wound Management, Egypt, Overall Volume (Units), Historic,
2000-2007 62
Figure 47: Advanced Wound Management, Egypt, Overall Volume
(Units), Forecast, 2007-2012 63
Figure 48: Advanced Wound Management,
Egypt, Average Price ($), Historic, 2000-2007 64
Figure 49: Advanced Wound
Management, Egypt, Average Price ($), Forecast, 2007-2012 65
Figure 50:
Advanced Wound Management, Egypt, Distribution Share (%), 2006 66
Figure
51: Advanced Wound Management, Egypt, Company Share (%), 2006 67
Figure
52: Traditional Wound Management, Egypt, Overall Revenues ($ mn), Historic,
2000-2007 68
Figure 53: Traditional Wound Management, Egypt, Overall
Revenues ($ mn), Forecast, 2007-2012 69
Figure 54: Traditional Wound
Management, Egypt, Overall Volume (Units), Historic, 2000-2007 70
Figure
55: Traditional Wound Management, Egypt, Overall Volume (Units), Forecast,
2007-2012 71
Figure 56: Traditional Wound Management, Egypt, Average Price
($), Historic, 2000-2007 72
Figure 57: Traditional Wound Management,
Egypt, Average Price ($), Forecast, 2007-2012 73
Figure 58: Traditional
Wound Management, Egypt, Distribution Share (%), 2006 74
Figure 59:
Traditional Wound Management, Egypt, Company Share (%), 2006 75
Figure 60:
Compression Therapy, Egypt, Overall Revenues ($ mn), Historic, 2000-2007
76
Figure 61: Compression Therapy, Egypt, Overall Revenues ($ mn),
Forecast, 2007-2012 77
Figure 62: Compression Therapy, Egypt, Overall
Volume (Units), Historic, 2000-2007 78
Figure 63: Compression Therapy,
Egypt, Overall Volume (Units), Forecast, 2007-2012 79
Figure 64:
Compression Therapy, Egypt, Average Price ($), Historic, 2000-2007 80
Figure 65: Compression Therapy, Egypt, Average Price ($), Forecast, 2007-2012
81
Figure 66: Compression Therapy, Egypt, Distribution Share (%), 2006
82
Figure 67: Compression Therapy, Egypt, Company Share (%), 2006 83
Figure 68: Baxter International Inc., Value Chain Analysis 89
Figure
69: Covidien Ltd./Tyco Healthcare, Value Chain Analysis 104
Figure
70: 3M Company, Value Chain Analysis 121
Figure 71: Global Markets
Direct Methodology 141
|
Related Report
|
View Cart
